Skip to main content

Newsletter now in 4 languages

From 2025 we will send our newsletter in 4 languages: German, English, French and Italian. This is an important step for MEDCAN to better reach patients and medical professionals throughout Switzerland.

Multilingualism – a must

Switzerland is a multilingual country. With German, French and Italian as official languages ​​and a growing number of English speakers living here, it is essential to provide relevant information in different languages.

For many people, the medical use of cannabis is still a new topic. Interest has been growing since the law changed in 2022, which allows all doctors in Switzerland to prescribe cannabis. This development affects the whole of Switzerland, and that is why it is our job to ensure that every region has access to understandable and reliable information.

But it's not just about Switzerland. The situation in Europe varies from country to country, and many patients and professionals from other countries are interested in how the medical use of cannabis is regulated in Switzerland. Different languages ​​are crucial to educate people beyond national borders and to promote international exchange.

MEDCAN's commitment to multilingual education

MEDCAN has been offering all information on the website in four languages ​​for a year now. Hopefully we can reach everyone in Switzerland. From 2025 we will go one step further: we will also send our newsletter in German, English, French and Italian. Although this is additional work and a challenge for our small Association , we are convinced that the effort is worth it. Within just one month we were able to gain more than 20 new subscribers per language. This shows that there is a great need for reliable information on the medical use of cannabis in multiple languages.

A contribution to the European Enlightenment

With our commitment to multilingualism, we also contribute to the European debate on the medical use of cannabis. By providing multilingual information, we build bridges to countries where access to medical cannabis remains difficult - such as France. Our goal is to create a platform for knowledge and exchange - for patients, medical professionals and anyone interested in cannabis in medicine.

Subscribe to our newsletter now!

Stay informed and subscribe to our newsletter in your preferred language! Registration is possible directly via the homepage of our website. We will keep you up to date on all important developments relating to the medical use of cannabis.

Behind this work are Swiss cannabis patients who put their heart and soul into it. Support us with a membership or donation and help strengthen our voice.

 

Subscribe to the MEDCAN newsletter.

FQ“Learn how cannabis helps medically and how you can obtain it legally.”

Franziska Quadri, President MEDCAN